Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 3, 2026

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
06:43

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Published on: April 3, 2026

Pediatric dermatofibrosarcoma protuberans: multi-institutional outcomes.

Corey W Iqbal1, Shawn St Peter, Michael B Ishitani

  • 1Department of Surgery, Children's Mercy Hospitals and Clinics, Kansas City, Missouri, USA.

The Journal of Surgical Research
|March 25, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Delayed Inguinal Hernia Repair in Infants.

The Journal of surgical research·2025
Same author

Single-Incision Laparoscopic Ileocecectomy in Pediatric Crohn's Disease: A 15-Year Experience.

Journal of laparoendoscopic & advanced surgical techniques. Part A·2025
Same author

Switching lanes: No home antibiotics or laboratory testing prior to discharge in perforated appendicitis.

Journal of pediatric surgery·2025
Same author

Antibiotic monotherapy vs dual-drug therapy in perforated appendicitis: single-center retrospective review.

Pediatric surgery international·2025
Same author

Primary Ovarian Non-Gestational Placental Site Trophoblastic Tumor in a Pediatric Patient: A Case Report and Review of the Literature.

Pediatric blood & cancer·2025
Same author

Rapidly recurrent trichobezoar management.

BMJ case reports·2024

Dermatofibrosarcoma protuberans (DFSP) is a rare pediatric cancer. Prompt diagnosis and complete surgical excision with clear margins are crucial for successful treatment and preventing recurrence in children.

Area of Science:

  • Pediatric Oncology
  • Dermatopathology
  • Surgical Oncology

Background:

  • Dermatofibrosarcoma protuberans (DFSP) is an uncommon malignancy in the pediatric population.
  • DFSP presents with variable clinical manifestations, potentially leading to diagnostic delays.

Purpose of the Study:

  • To review the clinical characteristics, treatment, and outcomes of pediatric DFSP.
  • To emphasize the importance of accurate diagnosis and complete surgical resection for managing pediatric DFSP.

Main Methods:

  • Retrospective review of patients aged 18 years or younger diagnosed with DFSP between 1980 and 2010.
  • Analysis of treatment modalities, including excisional biopsy and re-excision, and patient follow-up data.

Main Results:

Related Experiment Videos

Last Updated: Jun 3, 2026

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
06:43

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Published on: April 3, 2026

  • Fifteen pediatric patients were identified, with a female predominance.
  • The median time to diagnosis was 182 days; most patients underwent re-excision with negative margins.
  • No recurrences were observed in patients with clear margins after re-excision; no adjuvant therapy was administered, and there were no disease-related deaths.

Conclusions:

  • Pediatric DFSP is a rare malignancy requiring prompt diagnosis.
  • Complete surgical excision with clear margins is the cornerstone of curative treatment for pediatric DFSP.
  • Variable presentation can delay diagnosis, highlighting the need for vigilance in pediatric dermatology and oncology.